Eli Lilly’s Claims Regarding Anti-Depressant Drug Cymbalta are Overstated

A new anlaysis of data claiming that Cymbalta relieves physical pain as well as the symptoms of depression, are overstated, according to Glen Spielmans, an assistant professor of psychology at Metropolitan State University in Minnesota. Professor Spielmans claims that Eli Lilly’s “Depression Hurts” campaign is a marketing effort that doesn’t live up to its own hype. Spielmans performed a meta-analysis of five published studies and found that Cymbalta has a minimal effect on physical or emotional pain. This is important since Spielmans does not receive drug industry funding and is arguably more objective in drawing conclusions. Once again, pharmaceutical companies can afford to spend lots of money on slick marketing campaigns that often have a tenuous relationship to the truth or scientific data.